Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Mastering Challenging Pharmacokinetic Dilemmas
Track:
Educational Sessions (CE)
Program Code: 263-L01
Date: Wednesday, December 9, 2009
Time: 2:00 PM to 4:30 PM EST
Location:
3205 - Murano
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Description
ACPE Activity #204-000-09-263-L01P
2.5 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: John E. Murphy, BS Pharm, PharmD, FASHP, Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:45 p.m.
Heparin and Low Molecular Weight Heparin Dosing in Difficult Situations
Brian L. Erstad, PharmD, FASHP, Professor, The University of Arizona, Tucson
2:45 p.m. – 3:10 p.m.
Methods for Estimating Renal Function: The Good, The Bad, The Ugly
Gary R. Matzke, PharmD, Professor, Virginia Commonwealth University / Medical College of Virginia, Richmond
3:10 p.m. – 3:40 p.m.
The Need for Consistency in Estimating Renal Function for Application to Drug Dosing Decisions
Thomas C. Dowling, PharmD, Associate Professor and Vice Chair, The University of Maryland, Baltimore
3:40 p.m. – 4:15 p.m.
The Evidence (or Lack) of Benefit from Renal Drug Dosing
John E. Murphy
4:15 p.m. – 4:30 p.m.
Questions, Answers, and Discussion
Learning Objectives:
2.5 Contact Hours / Knowledge-based
Educational Content: Level 2
Moderator: John E. Murphy, BS Pharm, PharmD, FASHP, Professor and Associate Dean, The University of Arizona College of Pharmacy, Tucson
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:45 p.m.
Heparin and Low Molecular Weight Heparin Dosing in Difficult Situations
Brian L. Erstad, PharmD, FASHP, Professor, The University of Arizona, Tucson
2:45 p.m. – 3:10 p.m.
Methods for Estimating Renal Function: The Good, The Bad, The Ugly
Gary R. Matzke, PharmD, Professor, Virginia Commonwealth University / Medical College of Virginia, Richmond
3:10 p.m. – 3:40 p.m.
The Need for Consistency in Estimating Renal Function for Application to Drug Dosing Decisions
Thomas C. Dowling, PharmD, Associate Professor and Vice Chair, The University of Maryland, Baltimore
3:40 p.m. – 4:15 p.m.
The Evidence (or Lack) of Benefit from Renal Drug Dosing
John E. Murphy
4:15 p.m. – 4:30 p.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Compare and contrast existing methods for estimating renal function.
- Describe populations for whom heparin and LMWH dosing recommendations, based on product information, are unavailable or potentially misleading.
- Evaluate evidence for the value in adjusting doses of renally excreted drugs in patients with diminished renal function.
- Explain difficulties in dosing heparin and low-molecular-weight heparin (LMWH) products in light of recommendations in published guidelines.
- Identify problems and potential solutions associated with predicting renal function.
This session is a part of:
Handout Online
